Patents by Inventor Yasunori Amaishi

Yasunori Amaishi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMPROVED DNA VACCINE FOR SARS-COV-2
    Publication number: 20230330214
    Abstract: Provided is DNA that: encodes a coronavirus (SARS CoV-2) spike protein or a fragment thereof; and has been optimized to partially or fully exhibit a codon included in a DNA sequence.
    Type: Application
    Filed: September 30, 2021
    Publication date: October 19, 2023
    Applicants: OSAKA UNIVERSITY, TAKARA BIO INC., ANGES, INC.
    Inventors: Hironori NAKAGAMI, Ryuichi MORISHITA, Hiroki HAYASHI, Yasunori AMAISHI, Sachiko OKAMOTO, Junichi MINENO, Hisato IKAI, Junko MICHIBATA, Takao KOMATSUNO
  • Chimeric antigen receptor
    Patent number: 9175308
    Abstract: Provided are a chimeric antigen receptor comprising an extracellular domain capable of binding to an antigen, a transmembrane domain and at least one intracellular domain, the chimeric antigen receptor being characterized in that an intracellular domain of a glucocorticoid-induced tumor necrosis factor receptor (GITR) is contained as the intracellular domain; a nucleic acid encoding the chimeric antigen receptor; a cell expressing the chimeric antigen receptor; and a method for producing the cell.
    Type: Grant
    Filed: October 5, 2012
    Date of Patent: November 3, 2015
    Assignees: MIE UNIVERSITY, TAKARA BIO INC.
    Inventors: Hiroshi Shiku, Yuki Orito, Junichi Mineno, Sachiko Okamoto, Yasunori Amaishi
  • CHIMERIC ANTIGEN RECEPTOR
    Publication number: 20140242701
    Abstract: Provided are a chimeric antigen receptor comprising an extracellular domain capable of binding to an antigen, a transmembrane domain and at least one intracellular domain, the chimeric antigen receptor being characterized in that an intracellular domain of a glucocorticoid-induced tumor necrosis factor receptor (GITR) is contained as the intracellular domain; a nucleic acid encoding the chimeric antigen receptor; a cell expressing the chimeric antigen receptor; and a method for producing the cell.
    Type: Application
    Filed: October 5, 2012
    Publication date: August 28, 2014
    Applicant: TAKARA BIO INC.
    Inventors: Hiroshi Shiku, Yuki Orito, Junichi Mineno, Sachiko Okamoto, Yasunori Amaishi